CORRECTED-Teva to sell its contraceptive brand Paragard in $1.1 bln deal
September 11, 2017 at 17:13 PM EDT
Sept 11 (Reuters) - Teva Pharmaceutical Industries , said it has agreed to sell Paragard, its intrauterine copper contraceptive brand, to a unit of Cooper Cos in a $1.1 billion cash deal.
